Swipe om te navigeren naar een ander artikel
The Fatigue Associated with Depression Questionnaire (FAsD) was developed to assess fatigue and its impact among patients with depression. The purpose of this study was to examine the questionnaire’s responsiveness to change and identify a responder definition for interpretation of treatment-related changes.
Data were collected at baseline and at 6 weeks from patients with depression starting treatment with a new antidepressant.
Of the 96 participants, 55.2% were women, with a mean age of 43.4 years. The total score and both subscales demonstrated statistically significant change with moderate to large effect sizes (absolute values ≥0.76). FAsD change scores were significantly correlated with change on the Brief Fatigue Inventory (r ≥ 0.73; p < 0.001). FAsD mean change scores discriminated among patient subgroups differing by degree of improvement in patient- and clinician-reported fatigue and depression. Responder definition for the two subscales and total score (0.67, 0.57, 0.62) was estimated primarily based on mean change among patients who reported a small but important improvement in fatigue.
The FAsD was responsive to change, and the responder definition may be used when interpreting treatment-related change. Results add to previous findings suggesting the FAsD is a useful measure of fatigue among patients with depression.
Kennedy, S. H. (2008). Core symptoms of major depressive disorder: Relevance to diagnosis and treatment. Dialogues Clin Neurosci, 10(3), 271–277. PubMed
Thase, M. E., Simons, A. D., McGeary, J., Cahalane, J. F., Hughes, C., Harden, T., et al. (1992). Relapse after cognitive behavior therapy of depression: Potential implications for longer courses of treatment. American Journal of Psychiatry, 149(8), 1046–1052. PubMed
Ogrodniczuk, J. S., Piper, W. E., & Joyce, A. S. (2004). Residual symptoms in depressed patients who successfully respond to short-term psychotherapy. Journal of Affective Disorders, 82(3), 469–473. PubMed
Maurice-Tison, S., Verdoux, H., Gay, B., Perez, P., Salamon, R., & Bourgeois, M. L. (1998). How to improve recognition and diagnosis of depressive syndromes using international diagnostic criteria. British Journal of General Practice, 48(430), 1245–1246. PubMed
Tylee, A., Gastpar, M., Lepine, J. P., & Mendlewicz, J. (1999). DEPRES II (Depression Research in European Society II): A patient survey of the symptoms, disability and current management of depression in the community. DEPRES Steering Committee. International Clinical Psychopharmacology, 14(3), 139–151. PubMedCrossRef
Swindle, R., Kroenke, K., & Braun, L. (Eds.). (2001). Energy and improved workplace productivity in depression. In Investing in Health: The Social and Economic Benefits of Health Care Innovation (Research in Human Capital and Development) (Vol. 14, pp. 323–341). Emerald Group Publishing Limited.
Fava, M. (2003). Symptoms of fatigue and cognitive/executive dysfunction in major depressive disorder before and after antidepressant treatment. Journal of Clinical Psychiatry, 64(Suppl 14), 30–34. PubMed
Baldwin, D. S., & Papakostas, G. I. (2006). Symptoms of fatigue and sleepiness in major depressive disorder. Journal of Clinical Psychiatry, 67(Suppl 6), 9–15. PubMed
Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56–62. CrossRef
Food & Drug Administration. (2009). Guidance for industry—patient-reported outcome measures: Use in medical product development to support labeling claims. Silver Spring, MD: FDA.
Kroenke, K., & Spitzer, R. L. (2002). The PHQ-9: A new depression diagnostic and severity measure. Psychiatric Annals, 32(9), 1–7.
Johns, M. W. (1991). A new method for measuring daytime sleepiness: The Epworth sleepiness scale. Sleep, 14(6), 540–545. PubMed
Guy, E. (Ed.). (1976). ECDEU assessment manual for psychopharmacology, revised. Rockville, MD: National Institute of Mental Health.
Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: Lawrence Erlbaum Associates.
Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2003). Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation. Medical Care, 41(5), 582–592. PubMed
Fleiss, J. L., Cohen, J., & Everitt, B. S. (1969). Large sample standard errors of kappa and weighted kappa. Psychological Bulletin, 72(72), 323–327. CrossRef
Wyrwich, K., Harnam, N., Revicki, D. A., Locklear, J. C., Svedsater, H., & Endicott, J. (2009). Assessing health-related quality of life in generalized anxiety disorder using the quality of life enjoyment and satisfaction questionnaire. International Clinical Psychopharmacology, 24(6), 289–295. PubMedCrossRef
- The Fatigue Associated with Depression Questionnaire (FAsD): responsiveness and responder definition
Louis S. Matza
Kathleen W. Wyrwich
Glenn A. Phillips
Lindsey T. Murray
Karen G. Malley
Dennis A. Revicki
- Springer Netherlands